Site Map

Instagram’s CEO knows you and Kylie Jenner are not happy the app is turning into TikTok
World’s richest family loses $11.4 billion in Walmart rout
A housing recession is the first step to a Fed-induced recession. Here’s where the housing market goes next
The next big threat to corporate diversity success is here
‘This is not going to be a quick fix’: Heathrow chief says travel chaos could last through next year
Junior bankers beware, top analyst says: ‘If you’re an employee of Wall Street, you better have your eyes wide open’
Wharton launches the first Ivy League crash course on the metaverse for business executives
Amazon Prime fees are going up in Europe, citing rising costs
Want your company’s A.I. project to succeed? Don’t hand it to the data scientists, says this CEO
Demand destruction is here as sky-high gas prices have nearly two-thirds of Americans changing their lifestyles
COVID is at or near record levels around the country. Scientists say one (pretty gross) indicator doesn’t lie
Big Tech is facing an unprecedented stress test—and the next 3 days will be key
The IMF is officially ‘gloomy’ as it slashes its outlook with the global economy ‘teetering on the edge’ of a return to the stagflationary 1970s
China has been waging a secret decade-long campaign targeting U.S. economic data, and the Fed’s defense is a joke, senator says
Reddit co-founder Alexis Ohanian says he’s ‘very serious’ about his offer to save the Choco Taco
Frontier and JetBlue are at a stalemate in months-long merger battle for Spirit
Billionaire Binance CEO CZ sues Businessweek’s Hong Kong publisher over ‘Ponzi scheme’ language
Bosses are oblivious to the real reason employees are quitting
Climate change’s freakishly hot summer is leading to a new type of insurance coverage—for heat stroke
TikTok ‘travel hack’ blamed by major airport chief for delaying disabled passengers
Facebook considers relaxing COVID-19 misinformation policies
Fast food founder buys $100,000 in lottery tickets, says he’ll share winnings with employees
HIV prevention drug PrEP is on trial as lawyer behind Texas abortion ban seeks to block coverage mandate under the ACA
Rome’s Colosseum has just been given an actual price tag — and it’s big
Yes, you’re allowed to cry at work now. Your coworkers think it’s weird if you don’t show emotion
Shopify is showing 1,000 staffers the door today as CEO admits he ‘bet’ on e-commerce—and he was wrong
Former CVS executive Helena Foulkes is running for Rhode Island governor on the strength of her business background: ‘It’s about getting stuff done’
Coinbase under investigation after outburst against SEC
Europe’s travel chaos set to get even worse as Lufthansa ground-staff strike causes 1,000 flight cancellations
Twitter hacker touting the data of over 5.4 million users, including celebrities and companies, for $30,000
Tech M&A’s surprising acceleration despite a sputtering economy
Billionaire twin brothers brawled on a luxury yacht over the control of their U.K. business empire, a London court hears
Employees are living—and working—longer. CEOs are introducing initiatives like phased retirements to harness the ‘longevity economy’
Mystery of global uptick in hepatitis affecting children may have been solved
A COVID outbreak in Shenzhen has forced 100 manufacturers into a ‘closed-loop’ system, threatening a new wave of supply-chain chaos
Beijing is trying to stop Pelosi from visiting the leading supplier of chips to the U.S., warning it is ‘seriously prepared’ to retaliate if she goes to Taiwan
New KPIs are ‘creating tensions in the C-suite,’ says an MIT researcher
Gen Z, rejoice: Most of the bosses who insist on return to office will retire soon
Low-carb diets: an expert explains how they work and if they’re right for you
Hybrid work is looking like a silver bullet for cutting down on employee churn
Distracted by the statistical debate over inflation? Here’s the real question
Amsterdam is tired of being Europe’s cheap flights hub
It’s time to expose the secret drug scam at the heart of American health care
Walmart woes show Americans are cutting their clothing budget as food costs rise
China just approved its first domestic anti-COVID pill, Azvudine, and is ready to produce 6.8 billion pills a year at half the price of Pfizer’s Paxlovid